Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate of 5%. Biomarkers for the early detection of pancreatic cancer are urgently needed. Transforming growth factor-beta1 (TGF-β1) is elevated in the tissues and plasma of patients with PDAC. However, no studies systemically report p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, J., Liang, Y., Yin, Q., Liu, S., Wang, Q., Tang, Y., Cao, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2016
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964897/
https://www.ncbi.nlm.nih.gov/pubmed/27464025
http://dx.doi.org/10.1590/1414-431X20165485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964897/
https://www.ncbi.nlm.nih.gov/pubmed/27464025
http://dx.doi.org/10.1590/1414-431X20165485

Ejemplares similares